Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

N/A
1(50.0%)
Phase 3
1(50.0%)
2Total
N/A(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04793932Phase 3Active Not Recruiting

Short-course Versus Long-course Pre-operative Chemotherapy With mFOLFIRINOX or PAXG (CASSANDRA TRIAL)

Role: lead

NCT05733130Recruiting

Italian Registry Chronic Pancreatitis

Role: lead

NCT06381362Recruiting

Italian Registry of Minimally Invasive Pancreatic Surgery

Role: lead

NCT05724992Not ApplicableRecruiting

Familial Pancreatic Cancer PROPHilation Program in Italy

Role: lead

NCT04095195Recruiting

Registry of Subjects at Risk of Pancreatic Cancer

Role: lead

All 5 trials loaded